Neuropharmacology of addiction

Psychiatry

Volumn 5, Issue 12, 2006, Pages 449-454

  Reid, Alastair ^a   Lingford Hughes, Anne ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

accumbens; addiction; alcohol; amygdala; cocaine; dopamine; ecstasy; glutamate; neuropharmacology; nicotine; opioid; orbitofrontal; withdrawal

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; AMFEBUTAMONE; BENZODIAZEPINE; CANNABINOID RECEPTOR; CANNABIS; CENTRAL STIMULANT AGENT; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR STIMULATING AGENT; GLUTAMIC ACID; NICOTINE; ONDANSETRON; OPIATE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ADDICTION; ALCOHOL ABUSE; ALCOHOLISM; AMYGDALOID NUCLEUS; ANTICIPATION; BRAIN; CANNABIS ADDICTION; COCAINE DEPENDENCE; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; HUMAN; LIMBIC SYSTEM; MOTIVATION; NEUROPHARMACOLOGY; NEUROPHYSIOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; ORBITAL CORTEX; PRIORITY JOURNAL; REVIEW; SENSATION; SENSITIZATION; STIMULUS RESPONSE; SUBSTANCE ABUSE; WITHDRAWAL SYNDROME;

EID: 33845352595     PISSN: 14761793     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.mppsy.2006.09.006     Document Type: Review

References (16)

1. Kreek M.J., LaForge K.S., and Butelman E. Pharmacotherapy of addictions. Nat Rev Drug Discov 1 (2002) 710-726
2. Lingford-Hughes A., and Nutt D. Neurobiology of addiction and implications for treatment. Br J Psychiatry 182 (2003) 97-100
3. Volkow N.D., and Li T.-K. The neuroscience of addiction. Nat Neurosci 8 (2005) 1429-1430
4. Daglish M., Lingford-Hughes A., and Nutt D. Human functional connectivity neuroimaging research in dependence. Rev Neurosci 16 (2005) 151-157
5. Koob G.F., and Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24 (2001) 97-129
6. Kalivas P.W., and Volkow N.D. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162 (2005) 1403-1413
7. Everitt B.J., and Robbins T.W. Neural systems of reinforcement for drug addiction: from actions to habits. Nat Neurosci 8 (2005) 1481-1489
8. Volkow N.D., Fowler J.S., and Wang G.J. The addicted human brain: insights from imaging studies. J Clin Invest 111 (2003) 1444-1451
9. Schultz W. Reward signaling by dopamine neurons. Neuroscientist 7 (2001) 293-302
10. Pilla M., Perachon S., Sautel F., et al. Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature 400 (1999) 371-375
11. Nutt D. Alcohol and the brain. Pharmacological insights for psychiatrists. Br J Psychiatry 175 (1999) 114-119
12. Pettinati H.M., Kranzler H.R., and Madaras J. The status of serotonin-selective pharmacotherapy in the treatment of alcohol dependence. Recent Dev Alcohol 16 (2003) 247-262
13. Iversen L. Cannabis and the brain. Brain 126 (2003) 1252-1270
14. Ricaurte G.A., DeLanney L.E., Irwin I., and Langston J.W. Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration. Brain Res 446 (1988) 165-168
15. Boot B.P., McGregor I.S., and Hall W. MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks. Lancet 355 (2000) 1818-1821
16. Parrott A.C., and Marsden C.A. MDMA (3,4-methylenedioxymethamphetamine) or ecstasy: the contemporary human and animal research perspective. J Psychopharmacol 20 (2006) 143-146